Avanos Medical AVNS Total Pain Management and Recovery — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's total pain management and recovery — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's total pain management and recovery — net sales?
- Avanos Medical (AVNS) reported total pain management and recovery — net sales of $56.3M in Q1 2026.
- How has Avanos Medical's total pain management and recovery — net sales changed year-over-year?
- Avanos Medical's total pain management and recovery — net sales increased by 0.2% year-over-year, from $56.2M to $56.3M.
- What is the long-term trend for Avanos Medical's total pain management and recovery — net sales?
- Over 4 years (2021 to 2025), Avanos Medical's total pain management and recovery — net sales has grown at a -2.7% compound annual growth rate (CAGR), from $264.8M to $237.8M.
- What does total pain management and recovery — net sales mean?
- Represents the total revenue generated from the sale of products and services within the Pain Management and Recovery segment, net of returns, allowances, and discounts. This is the primary measure of the segment's market demand and top-line performance. It serves as a critical indicator of the company's ability to successfully commercialize its medical device portfolio within this specific therapeutic area.